APOE and Alzheimer disease: This study demonstrates an association between AD-related HCIs and APOE ε4 gene dose in a large group of previously studied, cognitively normal, late-middle-aged ε4 homozygotes, heterozygotes, and non-carriers from the Arizona APOE cohort, and indeed, significant differences among the three genetic groups.